The Nomination Committee of Probi has now been appointed in accordance with the AGM resolutions.
AP4 is represented by Jannis Kitsakis, Portfolio Manager.
The other members in the committee is:
- Heniz-Jürgen Bertram, Symrise
- Marianne Flink, Swedbank Robur Fonder
- Bengt Jeppsson, Lund University
Probi is a Swedish publicly traded bioengineering company that develops effective and well-documented probiotics. Probi's products are available to consumers in more than 30 countries worldwide. In 2016 Probi had sales of 444 MSEK. The Probi share is listed on Nasdaq Stockholm.